Gaetano Di Guida

Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

RAS Inhibitors: Changing the Paradigm from the Undruggable.

RAS Inhibitors: Changing the Paradigm from the Undruggable.

Journal: Pharmaceutics
Published: April 30, 2026

When Lymph Nodes Don't Lie: Report of Three Unusual Presentations of Thoracic Tumors.

When Lymph Nodes Don't Lie: Report of Three Unusual Presentations of Thoracic Tumors.

Journal: Diagnostics (Basel, Switzerland)
Published: February 26, 2026

Proof-of-concept study of clinical use of blood-based MAVS biosensor in predicting immunotherapy response in SCLC patients.

Proof-of-concept study of clinical use of blood-based MAVS biosensor in predicting immunotherapy response in SCLC patients.

Journal: Translational oncology
Published: October 14, 2025

High prevalence of loss of Claudin-18 expression in invasive non-mucinous lung adenocarcinoma: Potential diagnostic implications in routine practice.

High prevalence of loss of Claudin-18 expression in invasive non-mucinous lung adenocarcinoma: Potential diagnostic implications in routine practice.

Journal: Histopathology
Published: August 20, 2025

Application of Telepathology for Rapid On-Site Evaluation of Touch Imprint Cytology in CT-Guided Percutaneous Transthoracic Core Needle Biopsy of Pulmonary Nodules: The Experience of Our Multidisciplinary Thoracic Tumor Board.

Application of Telepathology for Rapid On-Site Evaluation of Touch Imprint Cytology in CT-Guided Percutaneous Transthoracic Core Needle Biopsy of Pulmonary Nodules: The Experience of Our Multidisciplinary Thoracic Tumor Board.

Journal: Cancers
Published: March 31, 2025

Addition of metformin to anti-PD-1/PD-L1 drugs activates anti-tumor immune response in peripheral immune cells of NSCLC patients.

Addition of metformin to anti-PD-1/PD-L1 drugs activates anti-tumor immune response in peripheral immune cells of NSCLC patients.

Journal: Cell death & disease
Published: December 04, 2024

DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer.

DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer.

Journal: iScience
Published: August 20, 2024

Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept Study.

Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept Study.

Journal: Cancers
Published: July 08, 2024

PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer.

PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer.

Journal: Biomedicines
Published: February 29, 2024

CARdioimaging in Lung Cancer PatiEnts Undergoing Radical RadioTherapy: CARE-RT Trial.

CARdioimaging in Lung Cancer PatiEnts Undergoing Radical RadioTherapy: CARE-RT Trial.

Journal: Diagnostics (Basel, Switzerland)
Published: March 13, 2023

Role of Cardiac Biomarkers in Non-Small Cell Lung Cancer Patients.

Role of Cardiac Biomarkers in Non-Small Cell Lung Cancer Patients.

Journal: Diagnostics (Basel, Switzerland)
Published: December 01, 2022

Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review.

Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review.

Journal: Cancers
Published: October 25, 2022
Showing 1-12 of 13

Last Updated: 09/26/2026